Acro Biomedical Co., Ltd. (6748)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
180. 50
-14
-7.1979%
NT$
- Market Cap
- P/E Ratio
80% Div Yield
1.17M Volume
- Eps
NT$ 194.5
Previous Close Want to track 6748 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acro Biomedical Co., Ltd. (6748) Statistics
Valuation metrics
Market Cap -
Enterprise value 14.27B
Trailing P/E (ttm) -127.11
Forward P/E -
PEG ratio 13.42
Price/Sales (ttm) 296.24
Price/Book (mrq) 11.7
Enterprise Value/Revenue 281.26
Enterprise Value/EBITDA -142.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1M
Average volume (90 days) 1.09M
Price summary
52-Week low 57.3
52-Week high 310
Beta -
50-Day moving average 190.86
200-Day moving average 103.77
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Mar 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 53:50
Last split Date 8 Feb 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.01%
Operating margin -2.28%
Operational effectiveness
Return on assets -0.09%
Return on equity -0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.83
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.66
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.97
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 51.12%
Book value per share (mrq) 18.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
